-
CSL, a global bioengineering company, said the company would integrate its subsidiaries into one corporate family under the global CSL brand."As a goal-oriented organization, CSL has demonstrated excellent leadership in biotechnology for more than a century. It is the right time to develop sustainab
Bio
Marianne Chang
2022.08.16 12:27
-
Biosensor company i-SENS signed a memorandum of understanding with Meraki Place, a digital healthcare provider, to develop a chronic disease management service on Wednesday.Meraki Place runs a non-face-to-face medical treatment platform, My Doctor, and provides a one-stop service from treatment and
Bio
Kim Kee-won
2022.08.12 13:59
-
Local researchers have developed and proved the accuracy of a technology that can decipher the eyelid’s meibomian gland image using artificial intelligence.In the past, ophthalmologists measured meiboscore in degrees, a subjective reading method that lacks accuracy and reproducibility.Breaking away
Bio
Kim Kee-won
2022.08.11 14:56
-
Researchers at the Korea Research Institute of Biotechnology and Bioscience (KRIBB) have developed an ultra-small genetic scissor technology that significantly improved calibration efficiency.Genetic scissors technology removes, inserts, or replaces DNA from a specific base sequence in genes, as rep
Bio
Marianne Chang
2022.08.10 16:28
-
T&R Biofab said Wednesday that it signed a strategic joint development agreement with Johnson & Johnson Innovation to develop the 3D bio-printing scaffold technology.According to T&R Biofab, the contract’s purpose is to develop an implantable product in the body based on diverse biomaterials and bio
Bio
Kim Kee-won
2022.08.10 16:26
-
MiCo BioMed, an in-vitro diagnostic medical device maker, said Tuesday that it completed the clinical trial of the monkeypox testing kit and applied for its export approval to the Ministry of Food and Drug Safety (MFDS).In July, the company conducted a clinical trial of a monkeypox PCR testing kit (
Bio
Kim Kee-won
2022.08.09 11:56
-
The Korea Health Industry Development Institute (KHIDI) said on Tuesday that it would hold the "2022 Seoul Biomedical International Conference (2022 SIBC)" on Sept. 29 at the Seoul Metropolitan Government’s new office.City Hall hosts and the state agency organizes the sixth annual conference.The con
Bio
Marianne Chang
2022.08.09 11:49
-
The Lithuanian Biotechnology Association (LBTA) said on Friday that they signed a memorandum of understanding (MOU) with Korea Biotechnology Industry (Korea BIO) to establish stronger cooperation with Korean bio-companies in the field of high value-added technologies.In an interview with Korea Biome
Bio
Marianne Chang
2022.08.08 12:41
-
KT, the second-largest telco in Korea, has been accelerating its entry into the digital healthcare sector recently. Now, the company is seeking to expand its influence to lead the local healthcare ecosystem.“The healthcare industry is expanding from diagnosis and treatment to prevention and manageme
Bio
Lee Han-soo
2022.08.08 12:40
-
Huinno, a digital healthcare firm, said Friday the Ministry of Food and Drug Safety (MFDS) chose the company to provide technical support for a national project to adopt the international standards on the quality control of the latest medical devices.The project is jointly organized by Seoul Nationa
Bio
Marianne Chang
2022.08.05 17:04
-
Celltrion Healthcare said it has officially begun preparing to directly market its drugs in the U.S. by acquiring Celltrion USA from Celltrion.Celltrion Healthcare and Celltrion believe the acquisition will help maximize profits for both companies by strengthening each company's core competency and
Bio
Lee Han-soo
2022.08.05 16:50
-
Professor Virginijus Siksnys of the Institute of Biotechnology at Vilinus University opened the third and final day of Bio-Interplex (BIX) Korea 2022 with the keynote speech on the past, present and future of CRISPR-Cas technology on Friday at COEX, southern Seoul.CRISPR technology gained widespread
Bio
Marianne Chang
2022.08.05 13:49
-
On the opening day of Bioplus-Interphex (BIX) Korea 2022 on Wednesday, Korea Biomedical Review (KBR) spoke to a variety of foreign companies to discover their intentions for attending the event this year.At the forefront of discussions was healthcare digitalization.Merck gave an engaging presentatio
Bio
Marianne Chang
2022.08.04 16:23
-
Bioplus-Interphex Korea 2022, a bio-pharmaceutical exhibition and conference, opened on Wednesday with the Korean government vowing to give full support to the private sector that invests in the biotech industry.The event, co-organized by Korea Biotech Industry Organization (KoreaBIO) and Interphex,
Bio
Marianne Chang
2022.08.03 15:12
-
Genencell said Tuesday it obtained approval from Drugs Controller General of India (DCGI) to conduct phase 2/3 trial of ES16001 (pipeline name: GNC102), an oral Covid-19 treatment candidate.The biotech firm is conducting Covid-19 drug trials in multiple countries.In October, it received the nod to c
Bio
Park Gi-taek
2022.08.02 14:28
-
The Korea Atomic Energy Research Institute (KAERI) said Monday that its Advanced Radiation Technology Institute has developed a precision prediction model for radiation’s damage to DNA for the first time.By precisely predicting the level of radiation’s damage on DNA, medical professionals can evalua
Bio
Kim Kee-won
2022.08.01 16:04
-
Daesang Life Science said it signed a letter of intent (LOI) with Sinopharm International on Tuesday to establish a joint manufacturing and sales corporation for health foods in China’s Hainan Province.Under the accord, Daesang and Sinopharm International will collaborate on the health industry base
Bio
Marianne Chang
2022.07.27 16:38
-
A Seoul National University Bundang Hospital (SNUBH) research team has discovered a new gene mutation related to the cause of autism for the first time worldwide through a large-scale genetics study of autistic patients and their families.Autism is a developmental disorder characterized by repetitiv
Bio
Marianne Chang
2022.07.26 12:00
-
A Korea Advanced Institute of Science and Technology (KAIST) research team has discovered that protein-based neurotransmitter, somatostatin, could play a new role in improving toxicity in Alzheimer’s occurring mechanism.The study, led by Professor Lim Mi-hee of the Chemistry Department, was publishe
Bio
Kim Kee-won
2022.07.25 17:45
-
The National Cancer Center (NCC) said Monday that it has discovered a new targeted treatment for stage 3 or 4 progressive Hodgkin lymphoma patients, which improves their survival rate compared to existing standard treatments.Hodgkin's lymphoma is a rare blood cancer that occurs only in about 300 peo
Bio
Marianne Chang
2022.07.25 11:59
